You searched for "trust"
Winners announced for 2024 Hearing Technology Innovator Awards
Hearing Health & Technology Matters (HHTM), an online resource for hearing professionals and consumers with hearing loss, has today revealed the winners of its fifth annual Hearing Technology Innovator Awards™. Through this esteemed awards programme, HHTM continues to honour innovation...Opening ceremonies – a necessary evil?
This series of stories is dedicated to those of you with whom some of these moments were shared (or endured) and, above all, to my amazing and long-suffering husband, David Howard. Most of you know him as an exceptional head...Can we prevent chronic rhinosinusitis?
The old adage ‘prevention is better than cure’ is considered by Professor Hopkins in respect to chronic rhinosinusitis, a condition affecting around 10% of the adult population and associated with huge impact on quality of life and economic cost. A...BACO 2015: Meet the Key Brits
The triennial BACO is always a feast of academic and social activity – and BACO 2015 promises to be as busy as ever. We hear from three of the key British speakers who are making big contributions to this year’s...Developing medical devices for children: opportunities and challenges
The development of medical devices for infants and children lags significantly behind the development of devices for adults. While in the United States the Food and Drug Administration (FDA) has set up incentives for developing child age-specific pharmaceuticals, there is...Do you treat RRP?
Do you treat RRP? Please join the national Airway Intervention Registry: Recurrent Respiratory Papillomatosis (AIR: RRP) online database. This is a unique opportunity to contribute to a collaborative, UK-wide study collecting real world data on treatments for this rare but...
A new era in the treatment of recalcitrant nasal polyps?
Chronic rhinosinusitis with nasal polyps (CRSwNP) can be difficult to treat effectively in patients with aggressive or recalcitrant disease. Omalizumab (Xolair) is a monoclonal anti-IgE antibody with proven benefits for patients with moderate/severe asthma and CRSwNP, but this study looks...
Olfactory and gustatory recovery in coronavirus patients after six months
It remains unclear for how long olfactory and gustatory losses persevere in patients with COVID-19. This is a prospective study of 300 patients who lost taste and smell within seven days of contracting COVID-19. The patients were objectively assessed with...
Endovascular therapies for venous tinnitus
Tinnitus is an extremely vexing issue, not only for patients but also for otolaryngologists. The authors of this article review the causes of venous tinnitus, such as increased intracranial hypertension (IIH), dural venous sinus thrombosis and age-related anatomic variants. They...
Should we be utilising the pre-lacrimal approach for maxillary sinus inverted papilloma?
For some time now, gold standard management of the maxillary sinus inverted papilloma has been endoscopic medial maxillectomy (EMM). Recently the endoscopic prelacrimal recess approach (EPLRA) has been reported to provide good access whilst preserving the nasolacrimal duct and inferior...The future of rhinology
Over the last few decades, rhinology has been one of the most dynamic and progressive areas of ENT. Professor Fokkens is perfectly placed to offer insight into the future possibilities that could transform our patients’ care, many of which are...
